Brenntag has announced the commercial availability of the new Biopharma range BYPHAR, the company's three-tier product portfolio aimed at supporting biopharmaceutical manufacturers from early R&D through commercial production.
BYPHAR GMP samples for all products are now available and will be released from Brenntag’s Pharma GMP Hub.
BYPHAR is a raw material portfolio which Brenntag says is designed to "simplify raw material selection while helping manufacturers meet increasingly stringent regulatory and quality requirements."
Developed specifically for the biopharma sector, BYPHAR brings together Brenntag's global distribution capabilities, regulatory expertise and technical services into a single, structured offering that enables customers to select raw materials based on application criticality and manufacturing phase.
The portfolio supports manufacturers across monoclonal antibodies (mAbs), recombinant proteins, cell and gene therapies, vaccines, nucleic acid production, antibody-drug conjugates (ADCs), biosimilars and diagnostic manufacturing.
"BYPHAR represents a major step forward in how we support our biopharma customers," said Gearoid O'Rourke, Senior Director, Biopharma, Brenntag Pharma.
By combining high-quality raw materials and flexibility with global supply reliability and deep regulatory expertise, we are helping customers accelerate development and ensure the highest standards of all manufacturing stages.
The BYPHAR portfolio is organised into the following three product categories aligned with manufacturing risk, allowing manufacturers to select material grades appropriate to their process, risk profile and stage of development:
- BYPHAR Explore supports research and early-stage manufacturing with non-GMP materials for non-critical applications, compliant with relevant monographs and accompanied by essential regulatory documentation
- BYPHAR Enhance offers GMP-compliant raw materials for all biopharmaceutical manufacturing stages, produced per IPEC and EXCiPACT guidelines, with regulatory-ready documentation for qualification and validation
- BYPHAR Excel is designed for critical applications, providing LBLE raw materials made under GMP conditions. These multi-compendial products come with extensive regulatory documentation to ensure top quality and compliance.
Brenntag added that a dedicated customer portal will be available in August for customers to access product specifications, fact sheets and regulatory documentation packages.
Alongside Brenntag's own-label products, BYPHAR also has co-branded materials from established manufacturing partners including Budenheim, Citribel, K+S and Kerry.
The combined portfolio provides access to high-purity phosphates, citric acid and citrates, pharmaceutical-grade salts and acetates, supported by established manufacturing expertise and global supply capabilities.
